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Abstract
Introduction: Sepsis is one of the leading causes of childhood mortality, yet controversy surrounds the current treatment
approach. We conducted a systematic review to assess the evidence base for fluid resuscitation in the treatment of children
with shock due to sepsis or severe infection.
Methods: We searched 3 databases for randomized trials, quasi-randomized trials, and controlled before-after studies
assessing children with septic shock in which at least one group was treated with bolus fluids. The primary outcome was
mortality at 48 hours. Assessment of methodological quality followed the GRADE criteria. Relative risks (RRs) and 95%
confidence intervals (CI) were calculated and data pooled using fixed-effects method.
Results: 13 studies met our inclusion criteria. No bolus has significantly better mortality outcomes at 48 hours for children
with general septic shock (RR 0.69; 95%CI 0.54–0.89), and children with malaria (RR 0.64; 95%CI 0.45–0.91) when compared
to giving any bolus. This result is largely driven by a single, high quality trial (the FEAST trial). There is no evidence
investigating bolus vs no bolus in children with Dengue fever or severe malnutrition. Colloid and crystalloid boluses were
found to have similar effects on mortality across all sub-groups (general septic shock, malaria, Dengue fever, and severe
malnutrition).
Conclusions: The majority of all randomized evidence to date comes from the FEAST trial, which found that fluid boluses
were harmful compared to no bolus. Simple algorithms are needed to support health-care providers in the triage of patients
to determine who could potentially be harmed by the provision of bolus fluids, and who will benefit.
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Introduction
Sepsis is one of the leading causes of childhood mortality,
responsible for over half a million deaths world-wide [1]. Early
rapid fluid therapy is part of the standard package of care for
children with septic shock [2,3]. Despite decades of concern and
numerous practice guidelines, the use of fluid resuscitation in the
management of paediatric septic shock has, until recently, been
based on limited evidence. Recommendations to date have been
derived largely from experience of treating septic shock in adults
[4], and until recently were supported by data from non-
comparative cohorts of ionotrope-dependant children in a tertiary
care setting [5,6].
A recent systematic review that assessed differences in choice of
resuscitation fluids (colloid vs crystalloids) concluded that there was
insufficient evidence to make a definitive choice of fluids given the
weak evidence base [7]. However, this review did not look at the
question of whether or not fluid resuscitation improves outcomes.
Several trials have since been published, most notably a large
randomized-controlled trial, the FEAST trial, which found that
fluid bolus in fact increased mortality compared to no fluid bolus
[8]. Despite the large effect size of this trial, the results have led to
considerable controversy regarding the applicability of the trial
results to different contexts and populations [9–14], and to date no
revisions have been made to international and national guidelines
to reflect new trial findings.
We conducted a systematic review to assess the current evidence
base for fluid resuscitation in the treatment of children with shock
due to sepsis or severe infection.
Methods
Search Strategy
Our systematic review was conducted in accordance with the
PRISMA guidelines for reporting systematic reviews and meta-
analyses [15].
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Cochrane Central Register of Controlled Trials (CENTRAL) –
were searched independently and in duplicate by 2 reviewers (SH,
NF) from inception to February 29, 2012 with no geographical or
language restrictions using a compound search strategy detailed in
the pre-defined protocol (File S1). We additionally searched
bibliographies of relevant reviews and contacted experts in the
field in an attempt to identify relevant studies. Data extraction was
done independently and in duplicate by two reviewers (NF, SH).
The review sought randomized trials, quasi-randomized trials, and
controlled before-after studies assessing children with septic shock
and/or shock and severe infection (as defined by the studies) in
which at least one group was treated with bolus fluids. Studies that
only addressed non-infectious causes of shock, neonatal shock, or
patient populations with severe dehydration, were excluded
consistent with previous systematic reviews [7]. Studies in which
.30% of participants were considered to have septic shock were
included, but outcomes were not pooled. The primary outcome
was mortality at 48 hours. Secondary outcomes included mortality
at 4 weeks and adverse clinical events. Results were pooled
according to cause of septic shock.
Assessment of Methodological Quality
Individual studies were rated according to three main indicators
of methodological quality of randomized trials: allocation
concealment, loss to follow up ,20%, and reporting of adverse
events. For each category of septic shock, assessment of
methodological quality followed GRADE which rates evidence
according to four criteria: limitations, inconsistency, indirectness,
and imprecision. Publication bias was considered as a potential
limitation of the systematic review overall.
Data Analysis
Relative risks (RRs) and 95% confidence intervals (CI) were
calculated and data pooled using fixed-effects method, in which
the weight assigned the estimated treatment effect from a given
trial is proportional to the amount of information provided by that
trial. The robustness of this analysis was explored in sensitivity
analysis using the random-effects method [16]. Data were pooled
according to pre-defined subgroups depending on cause of sepsis
given differences in prognosis, and heterogeneity estimated by the
I
2 statistic. Point estimates and 95% CIs were calculated for the
frequencies of adverse events. All analyses were conducted using
Stata, version 12 (StataCorp LP, College Station, Texas, USA)
and GRADE Pro (www.gradeworkinggroup.org).
Results
Study Inclusions
The search strategy yielded 342 articles that were screened by
title and abstract. An additional 14 articles were identified through
bibliographic searches and contact with experts. In total, 13
studies met the inclusion criteria and were taken through for full
review [8,17–28]. Study inclusions as well as final exclusions are
detailed in Figure 1. Studies were done in populations with
malaria (4 studies), dengue fever (4 studies), and mixed causes of
septic shock (4 studies). In addition, one study was done in children
with severe malnutrition, in which over a third (34%) were
determined to have hypovolemic shock secondary to sepsis.
Baseline characteristics of included studies are summarised in
Table 1.
Assessment of Methodological Quality
The assessment of methodological quality of individual studies is
summarised in File S2. Overall, the methodological quality of
trials was high: most studies used allocation concealment (10/14)
and reported adverse events (12/14), and all had low rates of loss-
to-follow up. The GRADE evidence assessment for each category
of shock trial is summarised in File S3. For septic shock the quality
of the evidence was rated as high; this rating was driven largely by
the contribution of the FEAST trial. For malaria the quality of the
evidence was rated high if the FEAST trial data was considered,
otherwise it was rated as moderate, mainly due to imprecision. For
Dengue the quality of the evidence was rated as moderate; this was
due to the rating of serious imprecision driven by the low event
rate in trials. For malnutrition the quality of evidence was graded
as low because there was only a single, small trial.
Primary Outcomes
Primary outcomes of mortality at 48 hours are summarised in
Figure 1.
Four trials assessed interventions in children in septic shock
[8,17–19]. Overall mortality across all studies was 10.7%. These
studies provide evidence on four comparisons: no bolus vs colloid
bolus (2094 patients), no bolus vs crystalloid bolus (2091 patients),
colloids bolus vs crystalloid bolus (2157 patients), and different
formulations of crystalloid bolus (160 patients). The only
significant effect was found in the FEAST trial, the only large
trial to compare no bolus vs bolus; in this trial the no bolus group
(control) had a lower mortality compared to the bolus group (RR
0.69; 95% CI 0.54–0.89 [Figure 2]). There was no other difference
in mortality comparing crystalloid vs colloid (RR 1.01; 95%CI
0.80–1.28; I
2 0%; p=0.9 [Figure 3]).
Four trials (378 patients) assessed interventions in children with
shock associated with malaria infection [20–23]: a further 1793
children in the FEAST trial had malaria. Overall mortality across
all studies was 16.4%. The studies provide evidence comparing
bolus and no bolus (2005 patients), colloids vs crystalloids (118
patients), crystalloids vs maintenance therapy (133 patients), and
different formulations of colloid (167 patients). For this subgroup
of patients, no bolus was found to decrease mortality compared to
bolus (RR 0.64; 95%CI 0.45–0.91 [Figure 2]). Heterogeneity was
low (I
2 0%; p=0.7). This finding was unchanged using the
random-effects method (RR 0.65; 95%CI 0.46–0.92). No statis-
tically significant difference was found for any other comparison
(Figure 3).
Four trials (811 patients) assessed colloids vs crystalloids for the
treatment of children in dengue shock [24,26–28]. Overall
mortality was low at 1.3%. There was no difference in treatment
effects across arms (pooled RR 0.61; 95%CI 0.11–3.48). Hetero-
geneity was low (I
2 0%; p=0.7 [Figure 3]).
One trial was identified assessing the role of fluids in children
with severe acute malnutrition (61 patients, of whom 21 had sepsis)
[25]. This trial had high mortality (50.8%), but found no
difference between study groups which compared an isotonic
crystalloid (Ringer’s lactate) against two hypotonic crystalloids
(human albumin solution [HAS] or HSD/5D; RR 0.98; 95%CI
0.42–2.28 [Figure 3]).
Although the FEAST trial excluded children with severe
malnutrition, 70 (2%) children had a mid-upper-arm circumfer-
ence (MUAC) #11.5 cm (indicating severe acute malnutrition).
The effect of bolus fluids was not significantly different in children
with a mid-upper arm circumference of .11.5 cm (p=0.96) [29].
Fluid Bolus in Children with Septic Shock
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Only one study, the FEAST trial, reported mortality at four
weeks. Overall, no bolus was protective against mortality
compared to bolus (RR 0.69; 95%CI 0.54–0.87). Adverse clinical
events, reported by all studies, were low, irrespective of
intervention, and ranged from 0% to 11.1% (95%CI 4.2–22.6).
Interpretation
The majority of all randomized evidence to date comes from the
FEASTtrial,whichfoundthatfluidboluseswereharmfulcompared
to no bolus. The 2008 Surviving Sepsis Campaign Guidelines,
informed by a modified Delphi process, graded the current
paediatric recommendation (20 mL/kg boluses over 5–10 minutes
upto60 mL/kg)as2C,indicatingaweakrecommendationwithlow
quality of evidence [30]. Although a single trial, the evidence
provided by FEAST that fluid bolus are harmful compared to no
bolus is of high quality and sufficient precision, suggesting that the
withholding of bolus fluids should be considered for populations
similar to those enrolled in FEAST. The important question is the
extenttowhichtheseresultsareapplicabletootherpopulations.The
FEASTtrialexcludedpatientslikelytohavefluidlosseitherthrough
bleeding/burnsordehydrationduetogastroenteritis.Malnourished
children were also excluded. The study population did not include
neonates nor children with dengue fever. Caution must be taken in
extrapolating the findings beyond populations similar to those
included in this trial.
Much of the debate around the validity of the results of this trial
have focused on the applied definition of septic shock [9,14]. Part
of the difficulty rests on the fact that there are no uniform
definitions for septic shock and many guidelines lack stringent
criteria. A re-analysis of the trial data found the results to be robust
to the application of different definitions of shock, and while only
65(2%) of children fulfilled the strict WHO definition of shock,
even in this small subset there was a significant excess risk
associated with boluses with an absolute risk difference of 28%
(95%CI 3.4–52.5) [29].
Figure 1. Study inclusions and exclusions.
doi:10.1371/journal.pone.0043953.g001
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PLOS ONE | www.plosone.org 5 August 2012 | Volume 7 | Issue 8 | e43953Across all populations, there is no evidence that colloids are
superior to crystalloids. A previous systematic review of this
question published in 2010 reported outcomes from nine studies
(1230 children) and concluded that the evidence base is limited
[7]. This systematic review adds to the findings of the previous
review principally by including data from the FEAST trial, which
increases confidence in this conclusion within the limits of external
validity. Of note, more than half of patients enrolled in FEAST
had malaria, and overall mortality rates were similar in FEAST to
other malaria trials. For other specific populations such as Dengue
shock and shock associated with malnutrition, the evidence-base
remains limited. Nevertheless, the high rates of survival demon-
strated by the Dengue trials provides moderate evidence to
support fluid resuscitation for these patients.
There are several strengths and limitations to note. Strengths
include the restriction of inclusion of comparative trials and the
large meta-analytic dataset compared to previous reviews.
Limitations of the evidence-base include the small sample sizes
resulting in poor precision for specific populations, in particular
malnourished children. In addition, there is inconsistent reporting
of secondary outcomes, which limited analysis, although the most
important outcomes (mortality and adverse clinical events) were
reported by all studies. Few trials included a control group making
it impossible to assess the impact of the bolus itself in most trials.
Subgroup analyses carry the risk of spurious findings, but these
analyses were limited in number and pre-specified in the research
protocol. Another potential limitation of this review is the search
strategy (only 3 databases searched). Attempts were made to limit
the possibility of having missed studies by using a highly sensitive
search strategy and consulting with experts in the field. Publication
bias is an ever present risk of any systematic review. We were
unable to assess publication bias formally due to the limited
number of studies identified for review, but the results do not
appear to suggest publication bias. Finally, as highlighted by the
debate generated following the publication of the FEAST trial, the
lack of a standardised definition for shock is an important caveat to
consider when comparing different studies. Nevertheless, the
results of the FEAST trial were found to be robust to a range of
sensitivity analyses that applied different definitions of shock [29].
The most important direction for future research is the
applicability of the findings of the FEAST trial to other
populations and settings. Simple algorithms are needed to support
health-care providers in the triage of patients to determine who
could be potentially be harmed by the provision of bolus fluids,
and who will benefit. Further studies are urgently needed in the
area of shock associated with malnutrition, because the evidence
base is scant and mortality high. Work is needed to establish a
uniform definition of shock to assist in the comparability of future
studies and the application of practice guidelines. The FEAST trial
used relatively modest fluid boluses in both rate and time of
infusion compared to the other trials included and in comparison
to current guidelines. Despite these conservative volumes and
rates, bolus therapy was still found to be harmful. Finally, more
research is needed to determine exactly what role for fluid therapy
in this population beyond the use of bolus therapy.
Conclusions
The majority of all randomized evidence to date comes from a
single trial, which found that fluid boluses were harmful compared
Figure 2. Forest plot for the outcome of mortality comparing no bolus and bolus.
doi:10.1371/journal.pone.0043953.g002
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PLOS ONE | www.plosone.org 6 August 2012 | Volume 7 | Issue 8 | e43953to no bolus. While this finding cannot be applied broadly, it does
provide for the first time strong evidence on which to base
guidelines for management of paediatric septic shock. In the
subpopulation of children with haemorrhagic dengue fever, there
is moderate evidence to support fluid resuscitation. A priority for
future operational research, therefore, is the definition of practical
guidelines and algorithms that will allow health-care providers to
distinguish between those groups of children likely to benefit from
fluid bolus, and those children who could be harmed by this
intervention.
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